mhurhangee/patent-ind-claim-en huggingface dataset:
A nuclear fission reactor comprising: a reactor vessel ; a fission region within the reactor vessel; a fertile blanket region in the reactor vessel, the fertile blanket region being in hydraulic communication with the fission region and neutronic communication with the fission region; a solution , received in the fission region and the fertile blanket region, the solution including a first fissile nuclear fission fuel material dissolved in neutronically translucent liquid carrier material; and a solid, undissolved fertile nuclear fission fuel material in the fertile blanket region and in direct physical contact with the solution, the fertile nuclear fission fuel material being transmutable into a second fissile nuclear fission fuel material, the second fissile nuclear fuel material being diffusible into the solution within the reactor vessel. a reactor vessel ; a fission region within the reactor vessel; a fertile blanket region in the reactor vessel, the fertile blanket region being in hydraulic communication with the fission region and neutronic communication with the fission region; a solution , received in the fission region and the fertile blanket region, the solution including a first fissile nuclear fission fuel material dissolved in neutronically translucent liquid carrier material; and a solid, undissolved fertile nuclear fission fuel material in the fertile blanket region and in direct physical contact with the solution, the fertile nuclear fission fuel material being transmutable into a second fissile nuclear fission fuel material, the second fissile nuclear fuel material being diffusible into the solution within the reactor vessel.
System for descaling an internal combustion engine, descaling system comprising an injection means arranged so as to inject a cleaning fluid over an inlet 5for the inflow of a fuel-air mixture of the running engine, descaling system characterized in that it also comprises a control means arranged so as to control an opening or closing of an EGR valve of the engine according to parameters of the injected cleaning fluid.
An inductive filtering device comprising multiple electric conductors (34; 47; 57; 62) grouped into the same winding and each intended to support a different electric voltage and at least two toroidal magnetic cores (12, 22; 41, 42, 43, 44; 51, 52, 54, 55; 82, 84; 90; 101, 102; 111, 112), each formed around a central recess (14, 24; 114), the two magnetic cores having different magnetic lengths (L 1 , L 2 ), the electric conductors being wound together around the two magnetic cores by passing through the central recesses of the two magnetic cores, the winding being formed by multiple turns, each turn of the winding being produced by simultaneously winding said multiple electric conductors (34a, 34b; 47a, 47b, 47c; 57a, 57b), wherein the toroidal magnetic cores (12, 22; 41, 42, 43, 44; 51, 52, 54, 55; 82, 84; 90; 101, 102; 111, 112) are formed from different materials, the material of the magnetic core with the shortest magnetic length (L 1 ) having a relative maximum magnetic permeability that is less than or equal to 3 000 and is lower than that of the material of the magnetic core with the largest magnetic length (L 2 ).
A method of preparing an additive composition for a release coating composition, said method comprising: preparing a branched cyclic polyorganohydrogensiloxane compound by reacting together: (A) a hydroxyl terminated polydiorganosiloxane of formula where subscript n is 2 to 2,000 and each R 1 is independently selected from the group consisting of monovalent hydrocarbon groups and monovalent halogenated hydrocarbon groups; and (B) a cyclic polyorganohydrogensiloxane of formula (RHSiO 2/2 ) v , where subscript v is 3 to 12 and each R is an independently selected monovalent hydrocarbon group; in the presence of (C) a boron containing Lewis acid; and combining the branched cyclic polyorganohydrogensiloxane compound with (D) a polyorganohydrogensiloxane diluent having the formula: H x R 3-x SiO(SiR 2 O) y (SiRHO) z SiR 3-x' H x ', where R is defined above, subscripts x and x' are each independently 0 or 1, subscript y is from 0 to 250, and subscript z is from 0 to 250, with the provisos that y+z≥1 and z+x+x'≥2. thereby preparing the additive composition. preparing a branched cyclic polyorganohydrogensiloxane compound by reacting together: (A) a hydroxyl terminated polydiorganosiloxane of formula where subscript n is 2 to 2,000 and each R 1 is independently selected from the group consisting of monovalent hydrocarbon groups and monovalent halogenated hydrocarbon groups; and (B) a cyclic polyorganohydrogensiloxane of formula (RHSiO 2/2 ) v , where subscript v is 3 to 12 and each R is an independently selected monovalent hydrocarbon group; in the presence of (C) a boron containing Lewis acid; and (A) a hydroxyl terminated polydiorganosiloxane of formula where subscript n is 2 to 2,000 and each R 1 is independently selected from the group consisting of monovalent hydrocarbon groups and monovalent halogenated hydrocarbon groups; and (B) a cyclic polyorganohydrogensiloxane of formula (RHSiO 2/2 ) v , where subscript v is 3 to 12 and each R is an independently selected monovalent hydrocarbon group; in the presence of (C) a boron containing Lewis acid; and combining the branched cyclic polyorganohydrogensiloxane compound with (D) a polyorganohydrogensiloxane diluent having the formula: H x R 3-x SiO(SiR 2 O) y (SiRHO) z SiR 3-x' H x ', where R is defined above, subscripts x and x' are each independently 0 or 1, subscript y is from 0 to 250, and subscript z is from 0 to 250, with the provisos that y+z≥1 and z+x+x'≥2. thereby preparing the additive composition.
A composition comprising an oncolytic virus for use in treating cancer in a mammal identified as having cancer cells that have a virotherapy permissive interferon (IFN)-stimulated gene (ISG) signature, wherein said ISG signature comprises at least 6 ISGs selected from the group consisting of HLA-A, HLA-B, HLA-C, HLA-E, HLA-G, IFI27, IFI35, IFI6, IFITI, IFIT3, IRF1, IRF2, IRF9, ISG15, MX1, MX2, OAS1, OAS2, OAS3, OASL, SOCS1, and STAT2, wherein one of the genes is HLA-A, wherein said virotherapy permissive ISG signature comprises decreased levels of expression as compared to control cells, and wherein said cancer is glioblastoma or ovarian cancer. wherein one of the genes is HLA-A, wherein said virotherapy permissive ISG signature comprises decreased levels of expression as compared to control cells, and wherein said cancer is glioblastoma or ovarian cancer.
A compound of formula (I): or a pharmaceutically acceptable salt or solvate thereof, wherein: R 1 is hydrogen or -C(O)R, wherein R is methyl or ethyl; R 2 is isopropyl, cyclopropyl, cyclopropylmethyl, or cyclopentyl; R 3 is methyl or ethyl; R 4 is hydrogen or fluoro; and R 5 is hydrogen or fluoro.
A system comprising: first and second hearing assistance devices each comprising a rechargeable lithium-ion power source and power management circuitry configured to control charging of the power sources; and a portable charging unit comprising: an interface configured to receive a connector of a power cable or a power and data cable; a rechargeable lithium-ion power source coupled to the interface; first and second charge ports configured to receive the first and second hearing assistance devices , and charging circuitry coupled to the first and second charge ports and to the rechargeable power source of the charging unit; wherein the power management circuitry and the charging circuitry are configured to cooperate to fully charge the power sources of the hearing assistance devices at a charge rate at or below 1.0C when a state of charge, SoC, of the power sources is outside a predetermined SoC range, and wherein the power management circuitry and the charging circuitry are configured to cooperate to partially charge the power sources of the hearing assistance devices at an accelerated charge rate above 1.0C when the SoC of the power sources is within the predetermined SoC range, and the predetermined SoC range is a range from a fully discharged state to about 45% wherein charging at the accelerated charge rate is terminated in response to reaching a predetermined time limit. first and second hearing assistance devices each comprising a rechargeable lithium-ion power source and power management circuitry configured to control charging of the power sources; and a portable charging unit comprising: an interface configured to receive a connector of a power cable or a power and data cable; a rechargeable lithium-ion power source coupled to the interface; first and second charge ports configured to receive the first and second hearing assistance devices , and charging circuitry coupled to the first and second charge ports and to the rechargeable power source of the charging unit; an interface configured to receive a connector of a power cable or a power and data cable; a rechargeable lithium-ion power source coupled to the interface; first and second charge ports configured to receive the first and second hearing assistance devices , and charging circuitry coupled to the first and second charge ports and to the rechargeable power source of the charging unit; wherein the power management circuitry and the charging circuitry are configured to cooperate to fully charge the power sources of the hearing assistance devices at a charge rate at or below 1.0C when a state of charge, SoC, of the power sources is outside a predetermined SoC range, and wherein the power management circuitry and the charging circuitry are configured to cooperate to partially charge the power sources of the hearing assistance devices at an accelerated charge rate above 1.0C when the SoC of the power sources is within the predetermined SoC range, and the predetermined SoC range is a range from a fully discharged state to about 45% wherein charging at the accelerated charge rate is terminated in response to reaching a predetermined time limit.
A system for creating a fistula between two vessels, comprising: a first catheter comprising a first magnetic element ; and a second catheter comprising a second magnetic element ; wherein at least one of the first and second catheters comprises a fistula-forming element , and wherein the first magnetic element is configured to produce a magnetic field that is stronger on a first side of the first magnetic element than on a second side of the first magnetic element, and further comprising a magnetic control device to be positioned externally to a body of a patient and for providing one or more magnetic forces to one or more of the catheters to be positioned in the body of a patient, comprising: a housing ; a magnet , wherein the magnet is moveable relative to the housing and is configured to increase the attractive force between the two catheters to help bring the catheters toward each other; and a control element fixedly connected to the magnet and moveably connected to the housing, wherein movement of the control element moves the magnet relative to the housing. a first catheter comprising a first magnetic element ; and a second catheter comprising a second magnetic element ; wherein at least one of the first and second catheters comprises a fistula-forming element , and wherein the first magnetic element is configured to produce a magnetic field that is stronger on a first side of the first magnetic element than on a second side of the first magnetic element, and further comprising a magnetic control device to be positioned externally to a body of a patient and for providing one or more magnetic forces to one or more of the catheters to be positioned in the body of a patient, comprising: a housing ; a magnet , wherein the magnet is moveable relative to the housing and is configured to increase the attractive force between the two catheters to help bring the catheters toward each other; and a control element fixedly connected to the magnet and moveably connected to the housing, wherein movement of the control element moves the magnet relative to the housing. a housing ; a magnet , wherein the magnet is moveable relative to the housing and is configured to increase the attractive force between the two catheters to help bring the catheters toward each other; and a control element fixedly connected to the magnet and moveably connected to the housing, wherein movement of the control element moves the magnet relative to the housing.
An apparatus for roasting coffee beans, comprising: a compartment for holding coffee beans ; a roasting element for roasting the coffee beans in the compartment; and a processor comprising a control unit for controlling the roasting element; characterized in that , the processor is adapted to determine a weight loss rate of the coffee beans, and the control unit is adapted to control the roasting element as a function of the determined weight loss rate of the coffee beans. a compartment for holding coffee beans ; a roasting element for roasting the coffee beans in the compartment; and a processor comprising a control unit for controlling the roasting element; characterized in that , the processor is adapted to determine a weight loss rate of the coffee beans, and the control unit is adapted to control the roasting element as a function of the determined weight loss rate of the coffee beans.
A composite coating comprising a primer and a topcoat, the primer being formed from an epoxy thermoset primer composition comprising: (i) an epoxy resin with the proviso that the epoxy resin does not have an EEW of 860 to 930; (ii) a polyhydroxyl functional phenolic curing agent having a HEW of 200 to 500; and (iii) a platy filler, wherein said epoxy thermoset primer contains zero zinc. (i) an epoxy resin with the proviso that the epoxy resin does not have an EEW of 860 to 930; (ii) a polyhydroxyl functional phenolic curing agent having a HEW of 200 to 500; and (iii) a platy filler,
An apparatus for lumen maintenance testing of light emitting diodes (LEDs) in accordance with the IESNA LM-80-2008 standard, the apparatus comprising: a chamber which is configured to heat or cool LEDs under test inside the chamber by ambient heating or cooling of the LEDs; at least one temperature sensor configured to sense the ambient temperature of air or other gas in the chamber; a temperature control unit configured to cause the ambient heating or cooling of the LEDs by increasing, decreasing or maintaining an ambient temperature inside the chamber, based on the sensed ambient temperature, wherein the temperature control unit is configured to temporally increase and maintain the ambient temperature according to predetermined requirements corresponding to those of the lumen maintenance test defined in the IESNA LM-80-2008 standard; and a light collecting unit located inside the chamber, wherein the light collecting unit is configured to continuously collect light emitted by the LEDs whilst the LEDs are being ambiently heated or cooled inside the chamber and to feed light collected from the LEDs via individual LED light measurement channels to a light analysis unit located outside of the chamber for continuous measurement while the LEDs are being ambiently heated or cooled inside the chamber. a chamber which is configured to heat or cool LEDs under test inside the chamber by ambient heating or cooling of the LEDs; at least one temperature sensor configured to sense the ambient temperature of air or other gas in the chamber; a temperature control unit configured to cause the ambient heating or cooling of the LEDs by increasing, decreasing or maintaining an ambient temperature inside the chamber, based on the sensed ambient temperature, wherein the temperature control unit is configured to temporally increase and maintain the ambient temperature according to predetermined requirements corresponding to those of the lumen maintenance test defined in the IESNA LM-80-2008 standard; and a light collecting unit located inside the chamber, wherein the light collecting unit is configured to continuously collect light emitted by the LEDs whilst the LEDs are being ambiently heated or cooled inside the chamber and to feed light collected from the LEDs via individual LED light measurement channels to a light analysis unit located outside of the chamber for continuous measurement while the LEDs are being ambiently heated or cooled inside the chamber.
A fluidic dispensing device comprising: a body including a base wall having an exterior base surface , and an interior perimetrical wall having a perimetrical end surface (150-3) and extending from the base wall to define a chamber ; an ejection chip mounted to a chip mounting surface (140-2) of the body, wherein the chip mounting surface (140-2) defines a first plane ; a diaphragm engaged with the perimetrical end surface (150-3) wherein the diaphragm comprises an exterior perimetrical rim (130-2); and a lid attached to the body , with the diaphragm interposed between the lid and the body wherein the lid comprises a diaphragm pressing surface and wherein the body and the lid define a split at a juncture of the lid and the body ; characterized in that during an ultrasonic welding process, a perimetrical gap is progressively reduced as a sacrificial material is melted from an exterior positioning lip of the lid and redistributed in joining the lid to the body , whereby a compressive force is applied to an exterior perimetrical rim (130-2) of the diaphragm by a diaphragm pressing surface of the lid ; and the diaphragm pressing surface of the lid forms a second lid having a downwardly facing perimetrical protrusion that is cone-like in cross-section, and engages the exterior perimetrical rim (130-2) of the diaphragm . a body including a base wall having an exterior base surface , and an interior perimetrical wall having a perimetrical end surface (150-3) and extending from the base wall to define a chamber ; an ejection chip mounted to a chip mounting surface (140-2) of the body, wherein the chip mounting surface (140-2) defines a first plane ; a diaphragm engaged with the perimetrical end surface (150-3) wherein the diaphragm comprises an exterior perimetrical rim (130-2); and a lid attached to the body , with the diaphragm interposed between the lid and the body wherein the lid comprises a diaphragm pressing surface and wherein the body and the lid define a split at a juncture of the lid and the body ; characterized in that during an ultrasonic welding process, a perimetrical gap is progressively reduced as a sacrificial material is melted from an exterior positioning lip of the lid and redistributed in joining the lid to the body , whereby a compressive force is applied to an exterior perimetrical rim (130-2) of the diaphragm by a diaphragm pressing surface of the lid ; and the diaphragm pressing surface of the lid forms a second lid having a downwardly facing perimetrical protrusion that is cone-like in cross-section, and engages the exterior perimetrical rim (130-2) of the diaphragm .
A system configured to monitor usage of a respiratory medicament delivery device , the medicament delivery device configured to deliver medicament to an airway of a subject , the medicament delivery device comprising an opening through which medicament is delivered to the subject, a cover configured to be removably installed at the opening in the medicament delivery device to cover the opening and a cover holder configured to removably couple to the cover , the system comprising: a power supply ; a processor ; and a switch configured to selectively connect and disconnect the power supply with the processor such that, responsive to the cover being removed from the opening, the switch connects the power supply with the processor to power up the processor, wherein the cover holder is connected to the switch by way of a tether , and wherein the tether is configured to actuate the switch responsive to the cover being removed from the opening in the medicament delivery device, and; wherein the processor is configured such that responsive to a power up, the processor causes information related to the power up to be recorded to non-transient electronic storage media. a power supply ; a processor ; and a switch configured to selectively connect and disconnect the power supply with the processor such that, responsive to the cover being removed from the opening, the switch connects the power supply with the processor to power up the processor, wherein the cover holder is connected to the switch by way of a tether , and wherein the tether is configured to actuate the switch responsive to the cover being removed from the opening in the medicament delivery device, and; wherein the processor is configured such that responsive to a power up, the processor causes information related to the power up to be recorded to non-transient electronic storage media.
Harvester header support for supporting a header of an agricultural harvester , which harvester header support comprises: - a frame , which frame comprises a harvester interface , which is connectable to an agricultural harvester , - a first support wheel , which is rotatable about a first support wheel axis , which first support wheel is mounted on a first support wheel shaft , - a coupling device , which is adapted to couple the first support wheel to the frame , which coupling device comprises: - a first coupling element , which is connected to the first support wheel shaft , and - a second coupling element , which is connected to the frame and to the first coupling element , the first and second coupling element being pivotable relative to each other over a pivot angle and about a first pivot axis , characterised in that : - the first pivot axis extends at a distance from and substantially parallel to the first support wheel axis , the coupling device has a forward travel mode and a rearward travel mode, in which forward travel mode the first coupling element is in a forward travel position relative to the second coupling element , and in which rearward travel mode the first coupling element is in a rearward travel position relative to the second coupling element , wherein the first coupling element is moveable from the forward travel position to the rearward travel position and/or vice versa by pivoting the first coupling element relative to the second coupling element about the first pivot axis . - a frame , which frame comprises a harvester interface , which is connectable to an agricultural harvester , - a first support wheel , which is rotatable about a first support wheel axis , which first support wheel is mounted on a first support wheel shaft , - a coupling device , which is adapted to couple the first support wheel to the frame , which coupling device comprises: - a first coupling element , which is connected to the first support wheel shaft , and - a second coupling element , which is connected to the frame and to the first coupling element , - the first pivot axis extends at a distance from and substantially parallel to the first support wheel axis , the coupling device has a forward travel mode and a rearward travel mode, in which forward travel mode the first coupling element is in a forward travel position relative to the second coupling element , and in which rearward travel mode the first coupling element is in a rearward travel position relative to the second coupling element , wherein the first coupling element is moveable from the forward travel position to the rearward travel position and/or vice versa by pivoting the first coupling element relative to the second coupling element about the first pivot axis .